| ANCA | Anti-neutrophil cytoplasmic antibody |
| Bcl-2 | B-cell lymphoma 2 |
| Bcl-6 | B-cell lymphoma 6 |
| CCI | Charlson Comorbidity Index |
| CD | Cluster of differentiation |
| CNS | Central nervous system |
| CRP | C-reactive protein |
| DNA | Deoxyribonucleic acid |
| ECOG | Eastern Cooperative Oncology Group |
| HIV | Human immunodeficiency virus |
| IPI | International Prognostic Index |
| IVLBCL | Intravascular large B-cell lymphoma |
| LDH | Lactate dehydrogenase |
| LEF-1 | Lymphoid enhancer-binding factor 1 |
| MUM1 | Multiple myeloma 1 |
| NHL | Non-Hodgkin’s lymphoma |
| NK cell | Natural killer cell |
| PD-L1 | Programmed death-ligand 1 |
| PD-L2 | Programmed death-ligand 2 |
| PET-CT | Positron emission tomography-computed tomography |
| sIL-2R | Soluble IL-2 receptor |
| SUVmax | Maximal standardised uptake value |
| 18F-FDG | Fluorodeoxyglucose (18F) |
| 3Y-OS | Three-year overall survival |
| 5Y-OS | Five-year overall survival |